Fairvalue-Calculator Fairvalue-Calculator
EN DE

Whan In Pharm Co (016580) Fair Value & Analysis

Healthcare · KR · Market cap 189B KRW

Price9,650 KRW
Fair Value15,181 KRW
Upside+57.3%
Quality95/100
Evidence: High Range 10,220 KRW – 20,227 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Whan In Pharm Co (016580) currently trades at 9,650 KRW, while our model-based Fair Value estimate is 15,181 KRW — implying the stock looks roughly 57.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and sedative, hypnotic, and autonomic nervous system medications. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Whan In Pharm Co (016580) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 15,181 KRW versus a price of 9,650 KRW — about +57% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 016580?
Our 21-model fair value for Whan In Pharm Co is 15,181 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 9,650 KRW.
What is the quality score of 016580?
Whan In Pharm Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.